Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
4
×
Tags
abbvie
4
×
biotech
4
×
boston blog main
clinical trials
crispr
4
×
life sciences
national blog main
san francisco blog main
allergan
alzheimer's disease
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
deals
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biogen
cancer immunotherapy
editas medicine
eli lilly
europe blog main
What
bio
roundup
companies
medicines
abbvie
acquisitions
alliance
announced
approval
biogen’s
biopharmaceutical
biotech
black
ceo
collabs
continue
convo
covid
daniel
deal
debut
diamond
diamond’s
drug
earlier
editas
editing
exits
experimental
failures
gene
genetic
gilead
gilead’s
help
indication
introduce
ipo
leading
life
Language
unset
Current search:
crispr
×
biotech
×
photo
×
abbvie
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More